Teva and Amgen Resolve Ongoing Dispute
Resilinc-blog

According to Business Wire News, Teva Pharmaceutical Industries resolved its ongoing dispute with Amgen over Teva’s generic cinacalcet HCl product, as announced on Wednesday, January 2.

Read All Global Disruptions

Recent Global Disruptions